Trillium Asset Management, LLC Adaptive Biotechnologies Corp Transaction History

Trillium Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$6.4 - $14.73 $263,827 - $607,214	-41,223 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$10.12 - $28.9 $2,044 - $5,837	-202 Reduced 0.49%	41,223 $572,000
Q4 2021 Feb 08, 2022	BUY	$25.17 - $36.85 $37,729 - $55,238	1,499 Added 3.75%	41,425 $1.16 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $122,691 - $162,948	4,087 Added 11.4%	39,926 $1.36 Million
Q2 2021 Aug 06, 2021	BUY	$32.22 - $44.59 $123,660 - $171,136	3,838 Added 11.99%	35,839 $1.46 Million
Q1 2021 May 10, 2021	BUY	$37.26 - $67.74 $1.19 Million - $2.17 Million	32,001 New	32,001 $1.29 Million

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Trillium Asset Management, LLC with notifications on news.